Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.050
-0.010 (-0.94%)
May 14, 2025, 11:00 AM - Market open
Dyadic International Employees
Dyadic International had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$582,565
Profits / Employee
-$968,193
Market Cap
31.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DYAI News
- 12 days ago - Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - GlobeNewsWire
- 27 days ago - Dyadic to Present at World Vaccine Congress | Washington - GlobeNewsWire
- 6 weeks ago - Dyadic International, Inc. (DYAI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Dyadic Reports 2024 Year-End Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025 - GlobeNewsWire
- 2 months ago - Dyadic to Attend Multiple Industry Events in March - GlobeNewsWire
- 4 months ago - Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology - GlobeNewsWire